Attapulgite Template for Oxygen Vacancies Boost of Manganese Dioxide Nanozymes With High Oxidase‐Like Activity

Why It Matters

Enhanced oxidase activity expands MnO2 nanozyme utility in biosensing and therapeutics, while the eco‑friendly template lowers production costs and improves biocompatibility.

Key Takeaways

• Attapulgite serves as inexpensive, biocompatible template.
• Hydroxyl groups facilitate oxygen vacancy formation in MnO2.
• Vacancies raise oxidase activity: Km 0.14 mM, Vmax 4.97e‑6.
• DFT confirms lowered energy barrier for Mn‑O bond breaking.
• Strategy enables scalable, green nanozyme manufacturing.

Pulse Analysis

Manganese dioxide nanozymes have emerged as versatile catalysts that mimic natural oxidases, finding use in biosensors, antimicrobial coatings, and therapeutic oxidation reactions. Their catalytic efficiency hinges on the density of oxygen vacancies, which act as active sites for substrate activation. Conventional methods to generate these vacancies often rely on expensive, synthetically derived templates that may introduce toxicity or hinder biocompatibility, limiting large‑scale biomedical deployment. Consequently, researchers have been seeking low‑cost, environmentally benign strategies that can reliably engineer vacancy‑rich MnO₂ structures without compromising safety.

The recent study leverages attapulgite, a naturally occurring clay mineral, as a green template to induce oxygen vacancies in MnO₂ nanozymes. Surface hydroxyl groups on the attapulgite weaken Mn‑O bonds, lowering the activation energy for vacancy formation, a mechanism validated by X‑ray photoelectron spectroscopy and density functional theory calculations. The resulting material exhibits a Michaelis constant of 0.14 mM and a maximum reaction velocity of 4.97 × 10⁻⁶ M·s⁻¹, outperforming previously reported MnO₂ catalysts and demonstrating the potency of vacancy engineering through a simple, scalable process.

This clay‑based approach delivers a dual advantage: it dramatically boosts catalytic performance while adhering to green chemistry principles, making the nanozyme suitable for clinical diagnostics and in‑vivo therapeutic applications where biocompatibility is paramount. The low material cost and straightforward synthesis also open pathways for mass production, potentially accelerating the commercialization of nanozyme‑driven devices. Future research may extend the attapulgite templating concept to other transition‑metal oxides, broadening the portfolio of high‑activity, sustainable nano‑catalysts for the biotechnology market.